Abstract

Functional MRI is integrated into routine imaging protocols for a number of tumour types. Diffusion weighted MRI is a functional MRI sequence which is common across most protocols. Assessments have traditionally focused on detailed local staging but advances in hardware and software have allowed whole body coverage and whole body diffusion weighted MRI in reasonable time frames. This non invasive, well tolerated and sensitive whole body imaging technique is providing novel insight particularly into myeloma and metastatic disease. This talk will explore the current status of whole body diffusion weighted MRI and will introduce the impact on clinical decision making in oncology.